|
株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.
Ministers Agreed on Off-year Revision - Settled on Coverage of "Deviation Rate of More than 5%", Prices to be Reduced for 70% of All Products
December 21st, 2020
Minister of Finance Taro Aso, Chief Cabinet Secretary Katsunobu Kato and Minister of Health, Labor and Welfare Norihisa Tamura discussed the FY2021 budget on December 17, 2020 and agreed that the off-year revision of NHI prices in next April would cover products with a deviation rate of more than 5.0%, which is 0.625 time the average deviation rate 8%. The revision will apply to 12,000 items, or 69% of all products, and the price of each product will be reduced to the actual selling price added with 2.8% of the selling price consisting of 2% adjustment range of weighted average of selling prices and 0.8% "Special exception for new coronavirus infection." About 60% of new drugs and 80% of generic drugs will be affected and the expected reduction of drug cost will be about 430 billion yen (or about 100 billion yen on a national expenditure basis). (See a related article in Page 2.)
(Continue to the next)
|
For this translated article in English, CM Plus Corporation shall have the copyright.
Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2020 LSMIP office / CM Plus Singapore Pte. Ltd.
Comments (Require approval)